Jove
Visualize
Contact Us

Related Experiment Videos

Sympathomimetics.

C K Aaron1

  • 1Division of Emergency Medicine, University of Massachusetts Medical Center, Worcester.

Emergency Medicine Clinics of North America
|August 1, 1990
PubMed
Summary

Sympathomimetic drug abuse is evolving, with newer compounds causing hallucinogenic effects alongside adrenergic symptoms. Physicians must recognize and treat patients exhibiting signs of sympathetic hyperactivity due to these potent substances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole.

Journal of toxicology. Clinical toxicology·2002
Same author

Pentobarbital for severe gamma-butyrolactone withdrawal.

Annals of emergency medicine·2001
Same author

Treatment of methanol poisoning with intravenous 4-methylpyrazole.

Annals of emergency medicine·1997
Same author

Regional intravenous infusion of calcium gluconate for hydrofluoric acid burns of the upper extremity.

Annals of emergency medicine·1997
Same author

Delayed peak serum valproic acid in massive divalproex overdose--treatment with charcoal hemoperfusion.

Journal of toxicology. Clinical toxicology·1996
Same author

Overdose of extended-release acetaminophen.

The New England journal of medicine·1995
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Toxicology
  • Emergency Medicine

Background:

  • Sympathomimetic drugs, including amphetamines, have a history of recreational abuse.
  • Drug development has led to more potent and complex sympathomimetic compounds with hallucinogenic properties.
  • Emergence of drugs like "ice" (methamphetamine) necessitates clinical awareness.

Purpose of the Study:

  • To highlight the evolving nature of sympathomimetic drug abuse.
  • To inform physicians about the signs and symptoms of sympathetic hyperactivity.
  • To emphasize the need for appropriate medical intervention in cases of sympathomimetic intoxication.

Main Methods:

  • Review of historical and current trends in sympathomimetic drug abuse.
  • Clinical observation of patients presenting with sympathomimetic toxicity.
  • Analysis of the pharmacological profiles of emerging designer drugs.

Main Results:

  • Initial abuse focused on amphetamines for their stimulant effects.
  • Current trends involve designer drugs with combined stimulant and hallucinogenic properties.
  • Sympathetic hyperactivity is a key clinical presentation.

Conclusions:

  • Physicians must be vigilant regarding novel and existing sympathomimetic substances.
  • Prompt recognition and management of sympathetic hyperactivity are crucial for patient outcomes.
  • Understanding the changing landscape of drug abuse aids in effective clinical practice.

Related Experiment Videos